ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Sunitinib-Teva 37.5 mg, Hartkapseln - 28
67781003 Teva Pharma AG
Sunitinib-Teva 37.5 mg, Hartkapseln15.02.2021
  15.02.2021
Sunitinib (L01XE04) 
WHO-DDD14.02.2026
07.16.10.28
07.16.10. 
A  
No 
IP 
PR  
k.A.PR
  
7680677810039Synthetika
  
Composition
sunitinibum 37.5 mg, mannitolum, povidonum K 25, carmellosum natricum conexum corresp. natrium max. 0.23 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula.
Packungsbestandteile
Capsules
 
Active AgentDose
Sunitinib37.5 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum)  
Ammoniae Solutio Concentrata  
Carmellosum Natricum Conexum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Magnesii Stearas  
Mannitol  
Povidonum K25  
Pro Capsula  
Propylenglycol  
Source
Data was imported : 04.03.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home